United Imaging Intelligence (UII) has reached another important achievement in its regulatory progress. In July 2025, the company received CE marking for 18 additional AI applications, making the total number of CE-certified medical AI products 31. This is the largest number of CE-certified medical AI products globally, highlighting UII’s position as a worldwide leader in regulated artificial intelligence for healthcare. It also shows the company’s continued effort to build trust in intelligent medical solutions.
Health Technology Insights: Pacific AI Expands Policy Suite for Global AI Compliance
The new certifications apply to different types of imaging, such as PET/CT, mammography, MRI, and CT, and are used for various diseases across the body. These tools help doctors in many areas of medicine, including neurology, oncology, heart care, lung conditions, and musculoskeletal health. By covering such a wide range of clinical needs, UII has set a standard not only for regulatory approval but also for the real-world value of its AI in everyday medical care.
Earlier CE approvals included solutions for cardiology, neurology, chest medicine, oncology, and nuclear imaging. Together, UII’s range of products covers the entire medical process, starting from early detection and diagnosis through treatment and research. The wide variety of applications shows how the company can use AI in daily practice to make a real difference in patient care across many medical fields.
Health Technology Insights: PatientFi Partners with Worth to Transform Healthcare Financing for Medical Procedures
In Europe, UII’s medical AI technologies are already being used in five countries, including Spain, Italy, Bosnia and Herzegovina, Poland, and Turkey. With these new certifications, the company plans to expand its reach further by working with hospitals and healthcare systems to offer quicker, safer, and more reliable medical services. This expansion also opens up new opportunities to form stronger partnerships with European healthcare providers looking for reliable AI solutions.
Along with its CE certifications, UII also has 15 clearances from the U.S. Food and Drug Administration and 15 Class III approvals from China’s National Medical Products Administration. Gaining recognition under the strictest global regulatory systems shows that UII is prepared for wide use. The company aims to drive ongoing innovation in medical AI to make healthcare more efficient, improve decision-making, and make advanced medical care more accessible to patients around the world.
Health Technology Insights: Mark Mikhael Joins MAHA PAC Board for Patient Care Advocacy
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
